BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 25737276)

  • 1. The yin and yang of kidney development and Wilms' tumors.
    Hohenstein P; Pritchard-Jones K; Charlton J
    Genes Dev; 2015 Mar; 29(5):467-82. PubMed ID: 25737276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wilms' tumour: connecting tumorigenesis and organ development in the kidney.
    Rivera MN; Haber DA
    Nat Rev Cancer; 2005 Sep; 5(9):699-712. PubMed ID: 16110318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The roles of microRNAs in Wilms' tumors.
    Yu X; Li Z; Chan MT; Wu WK
    Tumour Biol; 2016 Feb; 37(2):1445-50. PubMed ID: 26634744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wilms' tumor gene 1: lessons from the interface between kidney development and cancer.
    Torban E; Goodyer P
    Am J Physiol Renal Physiol; 2024 Jan; 326(1):F3-F19. PubMed ID: 37916284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identical genetic changes in different histologic components of Wilms' tumors.
    Zhuang Z; Merino MJ; Vortmeyer AO; Bryant B; Lash AE; Wang C; Deavers MT; Shelton WF; Kapur S; Chandra RS
    J Natl Cancer Inst; 1997 Aug; 89(15):1148-52. PubMed ID: 9262253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell types expressing the Wilms' tumour gene (WT1) in Wilms' tumours: implications for tumour histogenesis.
    Pritchard-Jones K; Fleming S
    Oncogene; 1991 Dec; 6(12):2211-20. PubMed ID: 1722569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of WT1 protein in fetal kidneys and Wilms tumors.
    Grubb GR; Yun K; Williams BR; Eccles MR; Reeve AE
    Lab Invest; 1994 Oct; 71(4):472-9. PubMed ID: 7967503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A developmental context for multiple genetic alterations in Wilms' tumor.
    Feinberg AP
    J Cell Sci Suppl; 1994; 18():7-12. PubMed ID: 7883796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nephron Progenitor But Not Stromal Progenitor Cells Give Rise to Wilms Tumors in Mouse Models with β-Catenin Activation or Wt1 Ablation and Igf2 Upregulation.
    Huang L; Mokkapati S; Hu Q; Ruteshouser EC; Hicks MJ; Huff V
    Neoplasia; 2016 Feb; 18(2):71-81. PubMed ID: 26936393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Wilms' tumour: reconciling genetics and biology.
    Van Heyningen V; Hastie ND
    Trends Genet; 1992 Jan; 8(1):16-21. PubMed ID: 1369730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the WT1 gene in Wilms' tumour.
    Haber DA; Housman DE
    Cancer Surv; 1992; 12():105-17. PubMed ID: 1322241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the PAX2 gene in human fetal kidney and Wilms' tumor.
    Eccles MR; Wallis LJ; Fidler AE; Spurr NK; Goodfellow PJ; Reeve AE
    Cell Growth Differ; 1992 May; 3(5):279-89. PubMed ID: 1378753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CTNNB1 mutations and overexpression of Wnt/beta-catenin target genes in WT1-mutant Wilms' tumors.
    Li CM; Kim CE; Margolin AA; Guo M; Zhu J; Mason JM; Hensle TW; Murty VV; Grundy PE; Fearon ER; D'Agati V; Licht JD; Tycko B
    Am J Pathol; 2004 Dec; 165(6):1943-53. PubMed ID: 15579438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Wilms' tumors and malformation complexes].
    Hata J; Fukuzawa R; Takata A; Kikuchi H
    Nihon Rinsho; 2000 Jul; 58(7):1419-25. PubMed ID: 10921316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nephroblastoma (Wilms' tumor): a model system of aberrant renal development.
    Re GG; Hazen-Martin DJ; Sens DA; Garvin AJ
    Semin Diagn Pathol; 1994 May; 11(2):126-35. PubMed ID: 7809506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A CTCF-binding silencer regulates the imprinted genes AWT1 and WT1-AS and exhibits sequential epigenetic defects during Wilms' tumourigenesis.
    Hancock AL; Brown KW; Moorwood K; Moon H; Holmgren C; Mardikar SH; Dallosso AR; Klenova E; Loukinov D; Ohlsson R; Lobanenkov VV; Malik K
    Hum Mol Genet; 2007 Feb; 16(3):343-54. PubMed ID: 17210670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miR-140-5p could suppress tumor proliferation and progression by targeting TGFBRI/SMAD2/3 and IGF-1R/AKT signaling pathways in Wilms' tumor.
    Liu Z; He F; OuYang S; Li Y; Ma F; Chang H; Cao D; Wu J
    BMC Cancer; 2019 Apr; 19(1):405. PubMed ID: 31035970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss or oncogenic mutation of DROSHA impairs kidney development and function, but is not sufficient for Wilms tumor formation.
    Kruber P; Angay O; Winkler A; Bösl MR; Kneitz S; Heinze KG; Gessler M
    Int J Cancer; 2019 Mar; 144(6):1391-1400. PubMed ID: 30367465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of native WT1 protein from frozen human kidney and Wilms' tumors.
    Iben S; Royer-Pokora B
    Oncogene; 1999 Apr; 18(15):2533-6. PubMed ID: 10229205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of heterozygosity at 2q37 in sporadic Wilms' tumor: putative role for miR-562.
    Drake KM; Ruteshouser EC; Natrajan R; Harbor P; Wegert J; Gessler M; Pritchard-Jones K; Grundy P; Dome J; Huff V; Jones C; Aldred MA
    Clin Cancer Res; 2009 Oct; 15(19):5985-92. PubMed ID: 19789318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.